Development and Validation of a Nomogram Prognostic Model for Patients With Advanced Non-Small-Cell Lung Cancer

Cancer Informatics - New Zealand
doi 10.1177/1176935119837547
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Development and Validation of a Nomogram Prognostic Model for Small-Cell Lung Cancer Patients

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P3.01-36 Prognostic Factors in Elderly Patients With Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Circulating Microparticles Are Prognostic Biomarkers in Advanced Non-Small Cell Lung Cancer Patients

Oncotarget
Oncology
2017English

Development and Validation of a Prognostic Nomogram for Progression-Free Survival in Patients With Advanced Renal Cell Carcinoma Treated With Pazopanib

Oncology
MedicineCancer ResearchOncology
2015English

Prognostic Significance of Tissue Polypeptidespecific Antigen (TPS) in Patients With Advanced Non-Small Cell Lung Cancer

Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
1995English

P2.17-18 a Prognostic Score for Patients Receiving Multimodal Treatment for Locally-Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Advanced Non-Small Cell Lung Cancer in Elderly Patients

Breathe
PulmonaryRespiratory Medicine
2012English

Circadian Function in Patients With Advanced Non-Small-Cell Lung Cancer

British Journal of Cancer
Cancer ResearchOncology
2005English

BAP1 Is a Good Prognostic Factor in Advanced Non-Small Cell Lung Cancer

Clinical and Investigative Medicine
Medicine
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy